China

Home / China / Latest

Sinopharm applies for vaccine market approval

chinadaily.com.cn | Updated: 2020-11-25 14:29

Share

Share - WeChat

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

Photo

G331 National Highway road trip launches in Jilin and Xinjiang

Young talents converge on Shanghai as WorldSkills nears

Chinese farming model benefits Global South

International media tour explores Shaanxi's historic sites and culture

High-tech methods refine border checkpoint work

Post-disaster recovery underway in Hainan after torrential rainfall

Latest

State Council News

China's economy in August 2026

Exclusive

How China's 'backyard program' works for Africa

Hands off! Do robots do it all by themselves?

Middle school students teach humanoid robots to dance!

Newsmaker

Trainer dedicates decades to coaching elite police dogs

Northwest China's striking tiger embroidery does roaring trade

Special Coverage

Loyalty and Honor without Borders

105th founding anniv. of the CPC

BACK TO THE TOP

English

中文

Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349

About China Daily

Advertise on Site

Expat Employment

FOLLOW US